Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-04-30, Stock:NVO, The news for the past five days is as follows:
2018-04-23: NEWS1: Analysts’ Recommendations for Eli Lilly & Co. on April 20.
2018-04-24: NEWS1: Tresiba Could Significantly Drive Novo Nordisk’s Revenue in 2018.NEWS2: Ozempic Could Be Potential Driver for Novo Nordisk in 2018.NEWS3: This Small Biotech Is Building on a Surprising Success.NEWS4: This Small Biotech Is Building on a Surprising Success.
2018-04-25: NEWS1: Analysts’ Views on Sanofi, Pre-1Q18 Earnings Release.NEWS2: A Review of Novo Nordisk’s Modern Insulin.NEWS3: Novo Nordisk’s New-Generation Insulins: Growth Driver for 2018?.NEWS4: Novo Nordisk’s Xultophy Expected to See High Growth in 2018.
2018-04-26: NEWS1: Novo Nordisk’s Saxendra Could Witness Solid Growth in 2018.NEWS2: Novo Nordisk’s Hemophilia Segment Could See Steady 2018 Growth.NEWS3: Emisphere Amends License Agreement with Novo Nordisk.NEWS4: Novo Nordisk’s Victoza Could See High Growth in 2018.NEWS5: BP Appoints Helge Lund To Succeed Carl-Henric Svanberg As Chairman.NEWS6: BP Appoints Helge Lund To Succeed Carl-Henric Svanberg As Chairman.
2018-04-27: NEWS1: Grifols, Novo expansions prompt $1.3M renovation of JoCo training center.NEWS2: Analyst Recommendations for Novo Nordisk in April.NEWS3: How Is Novo Nordisk Positioned before 1Q18?.

Answer: Decrease